13 results
DEF 14A
CRBU
Caribou Biosciences Inc
11 Aug 22
Definitive proxy
4:04pm
and oversee the HIV franchise. Before Gilead, he had an 11-year tenure at GlaxoSmithKline, where he held various positions in sales, product marketing … . Prior to her tenure in the biopharmaceutical industry, she had a career in clinical pharmacy serving as a Clinical Oncology Pharmacist at Seattle Cancer
8-K
EX-99.1
CRBU
Caribou Biosciences Inc
11 May 22
Caribou Biosciences Announces Appointment of David Johnson
4:07pm
treatments Complera® and Stribild®. Before Gilead, Mr. Johnson had an 11-year tenure at Glaxo Smith Kline, where he held various positions in sales, product
10-K
2021 FY
CRBU
Caribou Biosciences Inc
21 Mar 22
Annual report
4:19pm
-Stage Development, Senior Vice President of Clinical Development and Medical Affairs, and Head of Experimental Medicine at Seagen. Prior to her tenure
8-K
EX-10.1
34wfib4kfqh
19 Jan 22
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-99.1
qoyt1nk
25 Aug 21
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
4:11pm
8-K
EX-3.2
asj18 r0dv
28 Jul 21
Unregistered Sales of Equity Securities
4:05pm
S-1/A
EX-3.5
2xt239
19 Jul 21
IPO registration (amended)
6:09am
S-1
EX-10.26
u3rbnh
1 Jul 21
IPO registration
4:05pm
S-1
EX-3.3
2q1av7
1 Jul 21
IPO registration
4:05pm
DRS
EX-3.3
94aj0
7 May 21
Draft registration statement
12:00am
DRS
EX-10.23
dfpgjykb887cbddtwh
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next